← Open Payments lookup

WANDA MARELIS: Open Payments

NPI 1538789003 · LAWRENCE, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,675 in 38 payments from 9 companies in 2025. Trend: 2023 $193 · 2024 $949 · 2025 $1,675

Food & beverage: $1,584Education: $91
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)14$762
E.R. Squibb & Sons, L.L.C.5$270
ABBVIE INC.5$137
Novartis Pharmaceuticals Corporation1$116
Vanda Pharmaceuticals Inc.2$102
Otsuka America Pharmaceutical, Inc.4$102
Otsuka Pharmaceutical Development & Commercialization, Inc.3$84
Teva Pharmaceuticals USA, Inc.3$78
Lundbeck LLC1$25

Products named: CAPLYTA, COBENFY, REXULTI, VRAYLAR, LEQVIO, FANAPT, AUSTEDO XR, REJOYN.

Industry payments across MA — which companies pay providers there.